RSS Feeds
Search

Out-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 1..10 of 48 - per page Next page
Order by
Processes for Preparing Nanowire Scaffolds on Metallic Substrates and Uses of the Scaffolds (07-42)
Medical and dental uses of biocompatible nanofiber scaffolds More
Cell-Nanofiber Composite Based Engineered Cartilage
A tissue-engineered cartilage derived from a cellular composite made from a biodegradable, biocompatible polymeric nanofibrous matrix More
Locomotion Induction by Electrical Stimulation of the Spinal Cord (88-07)
Method and Device More
Cell-Nanofiber Composite and Cell-Nanofiber Composite Amalgam Based Engineered Intervertebral Disc
Tissue engineered intervertebral discs comprising a nanofibrous polymer hydrogel amalgam having cells dispersed therein More
Rapid and Sensitive Detection of Nucleic Acid Sequence Variations
Mismatch-targeted transposition of Mu: a new strategy to map genetic polymorphism. More
Modulators of Nuclear Hormone Receptor Activity: Novel Compounds, Diverse Applications for Infectious Diseases, Including Anthrax (B. anthracis)
Novel agents that can interfere with the action of nuclear hormone receptors More
Tackling challenges of poor solubility
Enhancing the dissolution performance of small and large molecules in a range of dosage forms More
Stabilisation of biopharmaceuticals
Increasing the stability and improving the reconstitution of biomolecules using supercritical fluid (SCF) processing More
Optimised pulmonary/nasal therapies using supercritical fluid particle engineering
Crystal and particle engineering to form particles with strong aerodynamic performance and exceptional size uniformity for optimised pulmonary/nasal delivery More
10-2007-102 Collagomers – Local delivery system for the treatment of osteoarthritic (OA) joints, infections and Inflammation
Collagomers are bioadhesive micro and macro particles generated by linking a phospholipid to collagen. Collagomers entrap a wide range of molecules and release them slowly over long periods of time.They bind with high affinity to cells providing an... More
Displaying 1..10 of 48 - per page Next page
Order by

Related Reports

Market Research Reports provided by reports.innovaro.com
National Institute of Arthritis and Musculoskeletal and Skin Diseases – Developmental Therapeutics Review – Q4 2010
Nov 2010 - 40 pages - $500
National Institute of Arthritis and Musculoskeletal and Skin Diseases – Developmental Therapeutics Review – Q4 2010
Dec 2010 - 84 pages - $500
Musculoskeletal Pain Global Clinical Trials Review, Q1, 2011
Mar 2011 - 34 pages - $1,000
Musculoskeletal Disorders Pipeline Databook - November 2011
Nov 2011 - 7 pages - $3,835
Musculoskeletal Transplant Foundation - Medical Equipment - Deals and Alliances Profile
Mar 2011 - 16 pages - $250
MarketWatch: Biotechnology
Dec 2008 - 35 pages - $200
Deals and alliances in musculoskeletal diseases
Jun 2006 - 378 pages - $2,495
New Drug Futures 2009
Apr 2009 - 450 pages - $3,490
Musculoskeletal Disorders Therapeutics to 2016 - Introduction of Monoclonal Antibodies with First - in - class Mechanism of Action to Increase Treatment Options in Osteoporosis and Rheumatoid Arthritis
Oct 2010 - 169 pages - $3,500
Tamir Biotechnology, Inc – Product Pipeline Review – Q4 2010
Dec 2010 - 15 pages - $500
More Related Market Research Reports >>>

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2012 Innovaro Europe Ltd Innovaro Corporation All rights reserved. Terms and Conditions | Contact us